An interventional study of BestShape Go Intelligent Generation Transformable Electric Vehicle in Parkinson's Disease (PD) and Dementia, sponsored by Taipei Medical University Shuang Ho Hospital. Not yet recruiting at 1 site in Taiwan. Open to participants aged 50 Years to 85 Years. Per ClinicalTrials.gov, last updated 2025-12-10.
Sponsored by Taipei Medical University Shuang Ho Hospital · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 121 studies in Parkinson Disease with a site in Taiwan — 33 open to participants now, 37 under way, 1 of them phase 3. Parkinson Disease · Taiwan.
Among the 121 studies in Parkinson Disease with a site in Taiwan, this one is the 12th largest by planned enrollment of the 99 interventional ones that give a count, is one of 7 that started in 2026, is one of 72 with no phase, reaches primary completion later than 29 of the 36 other live ones, and was the 111th registered.
4,583 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.
Browse Parkinson Disease studies →33 of the 121 studies in Parkinson Disease with a site in Taiwan are open now. Recruiting first, the newest first:
National Taiwan University Hospital · Sites in Taiwan
Ages 18+
Serina Therapeutics · Sites in Taiwan, United States, Australia
Ages 40–80
Hoffmann-La Roche · Sites in Taiwan, United States, Australia and 14 more countries
Ages 50–85
National Taiwan University Hospital · Sites in Taiwan
Ages 18+ · Healthy volunteers
National Taiwan University Hospital · Sites in Taiwan
Ages 18–80
A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →
Of the 752 Parkinson Disease studies recruiting now, 314 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 64 take children under 18; 189 take healthy volunteers.
This study: 50 Years to 85 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
121 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 14 · Phase 3 9 · Phase 4 2
First in 2005; this study’s year is marked. 7 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 120 is above the median of 40 across 3,360 interventional studies indexed under Parkinson Disease.
Median enrollment 55 across the 99 interventional studies, 92 across the 22 observational. Of the 58 that completed or were terminated, 9 (16%) have results posted.
This tab as a report to print or save as PDF → With an account.
19 of 121 have an industry lead sponsor. The 10 most frequent:
Taipei Medical University Shuang Ho Hospital is the lead sponsor of 102 studies on the registry; 18 are open to participants now.
Taipei Medical University Shuang Ho Hospital has 5 studies filed under Parkinson Disease — fewer than ten, so there is no comparison to draw.
11 of the studies in Parkinson Disease with a site in Taiwan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06548256Kaohsiung Medical University Chung-Ho Memorial HospitalThe Clinical Application of Clostridium Butyricum Miyairisan for Motor and Non-motor Symptoms in Parkinson's Disease | 2026-12-31 |
| NCT07422675Serina TherapeuticsSAD Study in Patients With Parkinson's Disease and Motor Fluctuations | 2027-01-31 |
| NCT07172295National Taiwan University HospitalModulate Tremor Severity With Low-intensity Focused Ultrasound Stimulation Targeting the Deep Nucleus of Patients With Refractory Hand Tremor. | 2027-06-30 |
| NCT07028515National Taiwan University HospitalSelf-controlled Practice on Motor Learning and Motivation in Parkinson's Disease | 2027-07-31 |
| NCT07294469Taipei Medical University HospitalMenthol for Improving Movement and Sleep in Parkinson's Disease Patients | 2027-07-31 |
Add all 11 to your calendar (.ics) → With an account.
Among the 121 studies in Parkinson Disease with a site in Taiwan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to verify the safety and preliminary clinical benefits of long-term gait training using AI-powered smart electric vehicles for patients with neurodegenerative diseases such as Parkinson's disease and dementia.
This study is a single-center, prospective, open-label clinical intervention trial aimed at verifying the clinical safety and preliminary efficacy of an AI-powered smart electric vehicle in gait training for patients with Parkinson's disease and dementia. It is expected to recruit 120 participants aged 50-85 years, who will be randomly assigned to different training durations (2\~12 weeks), with training sessions conducted two or three times a week, each lasting 30 to 60 minutes. The primary assessment indicators include gait speed, number of falls, and gait confidence scale, while secondary assessments include satisfaction and balance function. All study data will be coded and preserved for 10 years. The study is funded by the "Healthy Taiwan Cultivation Plan."
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Gait abnormalities in patients with neurodegenerative diseases
Device: BestShape Go Intelligent Generation Transformable Electric Vehicle
The specific applications of artificial intelligence in intelligent electric vehicles mainly include gait monitoring and analysis, real-time feedback and guidance, autonomous adaptive assistance, safety prevention and warnings, data collection and longterm tracking, as well as adding interactive and entertainment elements.
Gait speed
Time frame: Before & after training (the training sessions will last for 2~12 weeks).
Gait length
Time frame: Before & after training (the training sessions will last for 2~12 weeks).
Number of falls
Time frame: During 2~12 training sessions.
Patients' gait confidence scale
Time frame: Before & after training (the training sessions will last for 2~12 weeks).
Patients' balance function
Timed-up-and-Go Test
Time frame: Before & after training (the training sessions will last for 2~12 weeks).
Patients' feedback
Clinical Global Impression (CGI)
Time frame: Before & after training (the training sessions will last for 2~12 weeks).
Start is estimated for Jan 2026; primary completion for Dec 2028, 35 months later.
Of 1,297 non-industry interventional studies with no phase under Parkinson Disease, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 35 months is above that.
Counting every sponsor, half of 1,373 studies reached it within 25 months; a quarter within 11 and three quarters within 44.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Taipei Medical University Shuang Ho Hospital →